Clinical study
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

https://doi.org/10.1016/S0735-1097(02)01854-5Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

This study aimed to evaluate the relationship between anemia and heart failure (HF) prognosis.

Background

Although it is known that chronic diseases, including HF, may be associated with anemia, the impact of hemoglobin (Hb) level on symptoms and survival in HF has not been fully defined.

Methods

We analyzed a cohort of 1,061 patients with advanced HF (New York Heart Association [NYHA] functional class III or IV and left ventricular ejection fraction [LVEF] <40%) referred to a single center for evaluation and management. The Hb level was drawn at time of initial evaluation. Patients were divided into quartiles of Hb: Hb <12.3; Hb 12.3 to 13.6; Hb 13.7 to 14.8; Hb >14.8 g/dl.

Results

Mean Hb was 13.6, and values ranged from 7.1 to 19.0 g/dl. The Hb groups were similar in age, medication profile, LVEF, hypertension, diabetes, smoking status and serum sodium. Lower Hb was associated with an impaired hemodynamic profile, higher blood urea nitrogen and creatinine, and lower albumin, total cholesterol and body mass index. Patients in the lower Hb quartiles were more likely to be NYHA functional class IV (p < 0.0001) and have lower peak oxygen consumption (PKVo2) (p < 0.0001). Survival at one year was higher with increased Hb quartile (55.6%, 63.9%, 71.4% and 74.4% for quartiles 1, 2, 3 and 4, respectively). On multivariate analysis adjusting for known HF prognostic factors, low Hb proved to be an independent predictor of mortality (relative risk 1.131, confidence interval 1.045 to 1.224 for each decrease of 1 g/dl).

Conclusions

In chronic HF, relatively mild degrees of anemia are associated with worsened symptoms, functional status and survival.

Abbreviations

BMI
body mass index
CAD
coronary artery disease
CI
confidence interval
ESRD
end-stage renal disease
Hb
hemoglobin
Hct
hematocrit
HF
heart failure
LVEF
left ventricular ejection fraction
MI
myocardial infarction
NYHA
New York Heart Association
PKVo2
peak oxygen consumption
RR
relative risk
SOLVD
Studies Of Left Ventricular Dysfunction

Cited by (0)

This study was supported by the Ahmanson Foundation, Los Angeles, California, and Amgen, Thousand Oaks, California.